EUVIMEDEUVIMED entdecken
Open Access

Three-Dimensional Dynamic Cell Models for Metabolic Dysfunction-Associated Steatotic Liver Disease Progression

Zhengxiang Huang, Lili Li, Kevin Dudley, Lan Xiao, Gary Huang iD, V Nathan Subramaniam, Chen Chen, Ross Crawford, Yin Xiao iD

BME Frontiers · 2025-01 · 6

DOI: 10.34133/bmef.0181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BME Frontiers, online erschienen am 30.09.2025. Verfasst von Zhengxiang Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Dentistry, Griffith University, Gold Coast, QLD 4222, Australia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Health and Medical Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a complex, progressive disorder involving multiple cell types, ranging from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), characterized by pro-inflammatory macrophage activation, and can eventually advance to fibrosis, initiated by hepatic stellate cells (HSCs). In vitro multi-cell coculture models are vital tools for elucidating the mechanisms underlying MASLD. Impact Statement: Existing in vitro models for MASLD, including traditional 2-dimensional (2D) cultures and advanced organ-on-a-chip and organoid systems, face challenges in representing multiple cell types and analyzing them individually. Here, utilizing a cell carrier developed in our laboratory, we introduce a series of 3D dynamic coculture models that simulate different stages of MASLD progression and enable individual cell type analysis.

Introduction

Currently, no single system provides an optimal balance of control, reproducibility, and analytical convenience. Most in vitro models lack the ability to isolate and analyze individual cell types post-culture, making it difficult to study cell-specific responses in MASLD progression.

Methods

The 3D hollow porous sphere cell carrier allows cells to grow on its surface, while the culture device (mini-bioreactor) creates a dynamic environment. The 3 distinct MASLD models were established based on cocultured cell types: steatosis (hepatocytes only), MASH (hepatocytes and macrophages in a 4:1 ratio), and fibrosis (hepatocytes, macrophages, and HSCs in an 8:2:1 ratio). Well-established MASLD mouse models were employed to validate our in vitro 3D dynamic MASLD models, using 7-week-old male C57BL/6J mice fed a high-fat diet.

Results

Our models demonstrate a progressive decline in hepatocyte viability and increased lipid accumulation, mirroring in vivo pathology. Additionally, gene expression profiles of our models align with those observed in MASLD-affected mouse livers. Notably, comparative analysis highlights the role of pro-inflammatory macrophages in disrupting hepatocyte lipid metabolism.

Conclusion

These models offer a robust platform for investigating MASLD mechanisms and show potential for screening anti-MASLD therapeutics.

Autor:innen und Institutionen

  • School of Medicine and Dentistry, Griffith University, Gold Coast, QLD 4222, Australia.
  • Institute for Biomedicine and Glycomics, Griffith University, Southport, QLD 4222, Australia.
  • School of Biomedical Sciences, University of Queensland, St Lucia, QLD 4072, Australia.
  • Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Research Institute of Stomatology, Nanjing University, Nanjing, China.
  • Central Analytical Research Facility, Queensland University of Technology, Brisbane, QLD 4000, Australia.
  • Hepatogenomics Research Group, Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD 4059, Australia.

ORCID-Profile: Gary Huang, Yin Xiao

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Huang, Z., Li, L., Dudley, K., Xiao, L., Huang, G., Subramaniam, V. N., Chen, C., Crawford, R., & Xiao, Y. (2025). Three-Dimensional Dynamic Cell Models for Metabolic Dysfunction-Associated Steatotic Liver Disease Progression. BME Frontiers, 6. https://doi.org/10.34133/bmef.0181

Vancouver

Huang Z, Li L, Dudley K, Xiao L, Huang G, Subramaniam VN, et al. Three-Dimensional Dynamic Cell Models for Metabolic Dysfunction-Associated Steatotic Liver Disease Progression. BME Frontiers. 2025;6. doi:10.34133/bmef.0181

BibTeX
@article{Huang2025,
  author = {Huang, Zhengxiang and Li, Lili and Dudley, Kevin and Xiao, Lan and Huang, Gary and Subramaniam, V Nathan and Chen, Chen and Crawford, Ross and Xiao, Yin},
  title = {Three-Dimensional Dynamic Cell Models for Metabolic Dysfunction-Associated Steatotic Liver Disease Progression},
  journal = {BME Frontiers},
  year = {2025},
  volume = {6},
  doi = {10.34133/bmef.0181}
}
Kostenlos starten →